DK4093383T3 - Ransdermalt terapeutisk system med den aktive ingrediens rotigotin og mindst en ikke-aminresistent silikoneklæber - Google Patents

Ransdermalt terapeutisk system med den aktive ingrediens rotigotin og mindst en ikke-aminresistent silikoneklæber

Info

Publication number
DK4093383T3
DK4093383T3 DK21702196.3T DK21702196T DK4093383T3 DK 4093383 T3 DK4093383 T3 DK 4093383T3 DK 21702196 T DK21702196 T DK 21702196T DK 4093383 T3 DK4093383 T3 DK 4093383T3
Authority
DK
Denmark
Prior art keywords
amine
active ingredient
silicone adhesive
therapeutic system
transdermal therapeutic
Prior art date
Application number
DK21702196.3T
Other languages
English (en)
Inventor
Björn Schurad
Gabriel Wauer
Christian Benda
Ulrike Kolling
Original Assignee
Luye Pharma Switzerland Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luye Pharma Switzerland Ag filed Critical Luye Pharma Switzerland Ag
Application granted granted Critical
Publication of DK4093383T3 publication Critical patent/DK4093383T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK21702196.3T 2020-01-24 2021-01-22 Ransdermalt terapeutisk system med den aktive ingrediens rotigotin og mindst en ikke-aminresistent silikoneklæber DK4093383T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20153621.6A EP3854388B1 (de) 2020-01-24 2020-01-24 Transdermales therapeutisches system mit dem wirkstoff rotigotin und mindestens einem nicht aminresistenten silikonkleber
PCT/EP2021/051500 WO2021148634A1 (de) 2020-01-24 2021-01-22 Transdermales therapeutisches system mit dem wirkstoff rotigotin und mindestens einem nicht aminresistenten silikonkleber

Publications (1)

Publication Number Publication Date
DK4093383T3 true DK4093383T3 (da) 2025-12-01

Family

ID=69191982

Family Applications (2)

Application Number Title Priority Date Filing Date
DK20153621.6T DK3854388T3 (da) 2020-01-24 2020-01-24 Transdermalt terapeutisk system omfattende rotigotin og mindst et ikke-aminresistent silikoneklæbestof
DK21702196.3T DK4093383T3 (da) 2020-01-24 2021-01-22 Ransdermalt terapeutisk system med den aktive ingrediens rotigotin og mindst en ikke-aminresistent silikoneklæber

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK20153621.6T DK3854388T3 (da) 2020-01-24 2020-01-24 Transdermalt terapeutisk system omfattende rotigotin og mindst et ikke-aminresistent silikoneklæbestof

Country Status (19)

Country Link
US (1) US20230218539A1 (da)
EP (2) EP3854388B1 (da)
JP (1) JP7835678B2 (da)
KR (1) KR20220131941A (da)
CN (1) CN115279351B (da)
AU (1) AU2021210611B2 (da)
BR (1) BR112022014665A2 (da)
CA (1) CA3165453A1 (da)
CL (1) CL2022001988A1 (da)
CO (1) CO2022011900A2 (da)
DK (2) DK3854388T3 (da)
ES (2) ES2966170T3 (da)
FI (2) FI3854388T3 (da)
HR (1) HRP20251425T1 (da)
MX (1) MX2022009114A (da)
PL (2) PL3854388T3 (da)
PT (2) PT3854388T (da)
SI (1) SI4093383T1 (da)
WO (1) WO2021148634A1 (da)

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4591622A (en) 1984-10-29 1986-05-27 Dow Corning Corporation Silicone pressure-sensitive adhesive process and product thereof
US4655767A (en) 1984-10-29 1987-04-07 Dow Corning Corporation Transdermal drug delivery devices with amine-resistant silicone adhesives
US5989586A (en) 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
DE19814084B4 (de) 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
DE19830898A1 (de) 1998-07-10 2000-01-13 Hexal Ag Vorrichtung zur Verbesserung der Entnahmefähigkeit von in Beuteln verpackten, haftklebend ausgerüsteten, flächigen Substratabschnitten
US6337086B1 (en) 1999-02-06 2002-01-08 Dow Corning Corporation Pressure sensitive adhesive compositions for transdermal drug delivery devices
AU2001292781A1 (en) 2000-09-19 2002-04-02 National Starch And Chemical Investment Holding Corporation Acryl adhesive useful in transdermal drug delivery systems
ATE246919T1 (de) 2001-05-08 2003-08-15 Sanol Arznei Schwarz Gmbh Verbessertes transdermales therapeutisches system zur behandlung von morbus parkinson
EP1256339B1 (en) 2001-05-08 2003-10-15 Schwarz Pharma Ag Transdermal therapeutic system for Parkinson's disease inducing high plasma levels of rotigotine
DE10220230A1 (de) 2002-05-06 2003-11-27 Sanol Arznei Schwarz Gmbh Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms
EP1386604A1 (en) 2002-07-30 2004-02-04 Schwarz Pharma Ag Improved transdermal delivery system
DE10234673B4 (de) 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
EP1386605A1 (en) 2002-07-30 2004-02-04 Schwarz Pharma Ag Improved transdermal delivery system for the administration of rotigotine
DE10261696A1 (de) 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
DE10334188B4 (de) 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10361259A1 (de) 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von Rotigotine in einem Frühstadium von Morbus Parkinson zur Prävention des weiteren Neuronenverlustes
DE102004014841B4 (de) 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
DE102006054731B4 (de) * 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
RS54235B1 (sr) 2007-11-28 2015-12-31 Ucb Pharma Gmbh Polimorfni oblik rotigotina
MX2010012989A (es) 2008-05-30 2011-04-27 Mylan Inc Sistema de suministro de farmaco transdermico estabilizado.
EP2298277A1 (en) * 2009-09-09 2011-03-23 Labtec GmbH Transdermal patch formulation
DE102009052972A1 (de) 2009-11-12 2011-09-15 Lts Lohmann Therapie-Systeme Ag Verfahren zur Verhinderung der Kristallisation von Arzneistoffen in einem Polymerfilm
HRP20181173T1 (hr) * 2009-12-22 2018-09-21 Ucb Biopharma Sprl Polivinilpirolidon za stabilizaciju čvrste disperzije nekristalnog oblika rotigotina
EP2457565A1 (de) 2010-11-29 2012-05-30 Ratiopharm GmbH Transdermales therapeutisches System enthaltend Rotigotin
WO2012084969A1 (en) 2010-12-22 2012-06-28 Hexal Ag Adhesive composition containing rotigotine and transdermal therapeutic system comprising the adhesive composition
US11534523B2 (en) * 2011-08-30 2022-12-27 Avery Dennison Corporation Silicone absorbent adhesive layer
TW201431570A (zh) * 2012-11-22 2014-08-16 Ucb Pharma Gmbh 用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片
WO2014198423A1 (de) * 2013-06-14 2014-12-18 Tesa Labtec Gmbh Dreischichtiges transdermales therapiesystem (tts)
JP6895755B2 (ja) * 2014-05-20 2021-06-30 エルテーエス ローマン テラピー−ジステーメ アーゲー 経皮送達システムにおける活性薬剤の放出を調節するための方法
JP7178072B2 (ja) * 2017-02-03 2022-11-25 コスメディ製薬株式会社 ロチゴチン含有経皮吸収型貼付剤
CN109806243B (zh) * 2017-11-20 2022-07-15 北京泰德制药股份有限公司 一种含有氟吡汀或其药用盐的皮肤外用贴剂

Also Published As

Publication number Publication date
CL2022001988A1 (es) 2023-05-19
AU2021210611B2 (en) 2025-12-18
CO2022011900A2 (es) 2022-10-31
EP3854388A1 (de) 2021-07-28
FI3854388T3 (fi) 2023-11-27
CN115279351A (zh) 2022-11-01
WO2021148634A1 (de) 2021-07-29
PL4093383T3 (pl) 2026-03-09
BR112022014665A2 (pt) 2022-10-11
PT3854388T (pt) 2023-12-11
AU2021210611A1 (en) 2022-08-18
EP4093383B1 (de) 2025-08-27
EP4093383A1 (de) 2022-11-30
CA3165453A1 (en) 2021-07-29
CN115279351B (zh) 2026-03-10
PT4093383T (pt) 2025-11-25
ES2966170T3 (es) 2024-04-18
MX2022009114A (es) 2022-10-27
ES3051624T3 (en) 2025-12-29
EP3854388B1 (de) 2023-10-04
HRP20251425T1 (hr) 2026-01-30
PL3854388T3 (pl) 2024-02-26
SI4093383T1 (sl) 2026-01-30
JP2023511964A (ja) 2023-03-23
FI4093383T3 (fi) 2025-11-28
JP7835678B2 (ja) 2026-03-25
KR20220131941A (ko) 2022-09-29
US20230218539A1 (en) 2023-07-13
DK3854388T3 (da) 2023-11-27

Similar Documents

Publication Publication Date Title
EP4349371A4 (en) DRUG CONJUGATE AND USE THEREOF
EP3765088A4 (en) TRANSDERMAL AND / OR DERMAL RELEASE OF LIPOPHILIC ACTIVE SUBSTANCES
EP4137197C0 (en) DRUG INJECTION TIP, HANDPIECE AND SKIN TREATMENT DEVICE
EP3723456C0 (en) SECURITY AND CARE SYSTEM FOR THE ELDERLY
KR102332488B9 (ko) 인체 자극 장치 및 상기 인체 자극 장치를 이용하는 인체 자극 방법
EP4134014A4 (en) Fastening nail, fastening nail implanting device and medical instrument
EP3682022A4 (en) HUMAN THERAPEUTIC TARGET MOLECULES AND MODULATORS THEREOF
KR20240101682A9 (ko) 이중특이 항체-캄프토테신 약물 접합체 및 이의 약학적 용도
EP4277573B1 (en) IMPLANTABLE MEDICAL DEVICES
EP4041064A4 (en) A medical therapeutic device
IL311331A (en) Pharmaceutical composition and use thereof
KR102353800B9 (ko) 인체 자극 유닛 및 상기 인체 자극 유닛을 가지는 인체 자극 장치
EP3634342C0 (de) Silikonpad mit wirkstoffen zur hautpflege und gegen hautalterung
IT201900020526A1 (it) Formulazione trifasica emulsionabile e suoi impieghi terapeutici e/o cosmetologici
EP3796877A4 (en) PACING AND TREATMENT DEVICE
EP4501373A4 (en) CONTINUOUS MEDICATION DEVICE AND MEDICAL TREATMENT SYSTEM
EP4032508A4 (en) ASSIST DEVICE AND ARTIFICIAL LIMB
EP4034113A4 (en) THERAPEUTIC FORMULATIONS AND THEIR USES
EP3917412C0 (en) SUTURE MANAGEMENT PROCESSES AND DEVICES
IL312874A (en) Pharmaceutical composition and use thereof
EP4255563A4 (en) 5'-o-phenylacetyluridine and therapeutic use
KR102316245B9 (ko) 인체 자극 장치 및 상기 인체 자극 장치를 이용하는 인체 자극 방법
EP4153091A4 (en) Penile implant device and method
DK3768265T3 (da) Ny centralt aktiv ghrelin-agonist og medicinske anvendelser deraf
PT4093383T (pt) Sistema terapêutico transdérmico com o princípio ativo rotigotina e pelo menos um adesivo de silicone não resistente a aminas